Phenformin and stanozolol in blood fibrinolytic activity.
作者信息
Menon I S, Cunliffe W J, Weightman D, Dewar H A
出版信息
Br Med J. 1970 Feb 14;1(5693):428. doi: 10.1136/bmj.1.5693.428.
Abstract
摘要
相似文献
1
Phenformin and stanozolol in blood fibrinolytic activity.血液纤维蛋白溶解活性中的苯乙双胍和司坦唑醇
Br Med J. 1970 Feb 14;1(5693):428. doi: 10.1136/bmj.1.5693.428.
2
3
Behçet's syndrome and oral fibrinolytic therapy.白塞氏综合征与口腔纤维蛋白溶解疗法。
Br Med J. 1973 May 26;2(5864):486-7. doi: 10.1136/bmj.2.5864.486-c.
4
5
Clinical and laboratory double-blind investigation on effect of fibrinolytic therapy in patients with cutaneous vasculitis.皮肤血管炎患者纤溶治疗效果的临床与实验室双盲研究
Br Med J. 1973 Apr 14;2(5858):82-4. doi: 10.1136/bmj.2.5858.82.
6
Failure of colchicine and fibrinolytic therapy in Behçet's disease.秋水仙碱和纤溶疗法对贝赫切特病治疗失败。
Clin Exp Dermatol. 1980 Mar;5(1):87-92. doi: 10.1111/j.1365-2230.1980.tb01672.x.
7
Treatment of Behcet's syndrome with phenformin and ethyloestrenol.
Lancet. 1969 Jun 21;1(7608):1239-40. doi: 10.1016/s0140-6736(69)92118-7.
8
Experiences in the use of fibrinolytic agents in Behcet's syndrome.白塞病中使用纤溶药物的经验。
Australas J Dermatol. 1972 Apr;13(1):5-10. doi: 10.1111/j.1440-0960.1972.tb00476.x.
9
Phenformin and ethyloestrenol for Raynaud's disease.苯乙双胍和乙基雌烯醇治疗雷诺病。
Lancet. 1969 Nov 29;2(7631):1203. doi: 10.1016/s0140-6736(69)92532-x.
10
The association between cutaneous vasculitis and decreased blood fibrinolytic activity.
Br J Dermatol. 1971 Feb;84(2):99-105. doi: 10.1111/j.1365-2133.1971.tb06850.x.
引用本文的文献
1
The effect of the anabolic steroid stanozolol on tissue plasminogen activator activity and plasmin inhibition in the rat.合成代谢类固醇司坦唑醇对大鼠组织纤溶酶原激活物活性及纤溶酶抑制作用的影响。
Experientia. 1980 Sep 15;36(9):1079-80. doi: 10.1007/BF01965980.
2
Metformin and stanozolol in blood fibrinolytic activity.二甲双胍与司坦唑醇对血液纤溶活性的影响
Br Med J. 1971 Jan 30;1(5743):289-90. doi: 10.1136/bmj.1.5743.289-c.
3
Antifibrin action of phenformin.
Diabetologia. 1975 Apr;11(2):105-11. doi: 10.1007/BF00429832.
本文引用的文献
1
Treatment of Behcet's syndrome with phenformin and ethyloestrenol.
Lancet. 1969 Jun 21;1(7608):1239-40. doi: 10.1016/s0140-6736(69)92118-7.
2
Role of the kidney in fibrinolytic activity of blood.
Lancet. 1968 Apr 13;1(7546):785-8. doi: 10.1016/s0140-6736(68)92230-7.
3
Fibrinolytic effects of diguanides plus ethyloestrenol in occlusive vascular disease.
Lancet. 1967 Nov 11;2(7524):1008-11. doi: 10.1016/s0140-6736(67)90286-3.
Zotero 插件